U.S. Markets open in 4 hrs, 31 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 26.82 11:30 AM EST | |
|---|---|---|
| Day High | 27.47 09:36 AM EST |
|
| Range | 0.65 |
| Volume | 368,050 | |
|---|---|---|
| 30-Day Avg Vol | 918,000 |
|
| Difference | -59.91% |
| Market Cap | 1.33 B | |
|---|---|---|
| Mkt Cap Chg | -6.41 M |
| Shares Out | 49.34 M | |
|---|---|---|
| % Shrs Traded | 0.75% | |
| 1yr EPS Est | -0.083 |
| 52-Wk Low | 6.14 | |
|---|---|---|
| 52-Wk High | 29.91 |
|
| Range | 23.77 |
| Prev Close | 27.10 2/8/10 | |
|---|---|---|
| Today's Open | 27.45 | |
| Change | 1.29% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.89 M |
| Revenue (LFY) | 178.76 M | |
|---|---|---|
| Earnings (LFY) | -47.04 M | |
| Earnings (MRQ) | -7.32 M | |
| Next Earn Est | -0.142 | |
| Next Earnings | 03/08/2010 |
|
| EPS (TTM) | -0.98 | |
| 1yr EPS Growth | 91.53% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -32.00 | |
| PEG Ratio | -0.75 | |
| Return on Equity | -17.22 | |
| Beta | 0.81 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Salix Pharmaceuticals is a finishing school for drugs. Focusing on gastrointestinal drugs, the company prefers to acquire drug candidates nearing commercial viability. It then takes them through the final ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.142 3/8/10 | — — |
—
—
|
| Last Quarter | -0.287 9/30/09 | -0.15 9/30/09 |
0.137
Beat
|
| 2 Quarters Ago | -0.351 6/30/09 | -0.32 6/30/09 |
0.031
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 65.66 M | 178.77 M |
| Gross Profit | 49.89 M | 125.06 M |
| Operating Income | -5.88 M | -46.66 M |
| Net Income | -7.32 M | -47.04 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts